This issue focuses on Confidential Commercial Information (CCI).
This is the second issue focused on Confidential Commercial Information (CCI), providing more details about applying for information to be declared as CCI.
The guidelines detail the requirements for, and the conditions of, accreditation.
This document provides further information about how to get accredited and how to stay accredited.
This document describes the Physical Containment (PC) levels used by the Gene Technology Regulator in the certification of facilities. It also explains the categories of organisms and types of dealings intended to be contained in each facility type and PC level.
This documents helps with the correct classification of NLRDs being included in the Record of Assessment for reporting online.
Transparency is a feature of the Regulator's decision making. This includes consultation on all licences for intentional release of genetically modified organisms (GMOs) into the environment, and on the revision of guidelines and development of amended regulations. Find out how you can contribute.
Gene technology is widely used in Australia: in agriculture, in research, in health and medicine, in education, and in industry.
Details on how the Gene Technology Regulator views requests to alter instruments of accreditation.
This guidance provides basic information to organisations in Australia wishing to conduct human clinical trials involving an experimental product that is, or contains, a genetically modified organism (GMO).